<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D9EFD5B9-6F3D-4279-8740-A4351E58710E"><gtr:id>D9EFD5B9-6F3D-4279-8740-A4351E58710E</gtr:id><gtr:name>Carl Zeiss AG</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D9EFD5B9-6F3D-4279-8740-A4351E58710E"><gtr:id>D9EFD5B9-6F3D-4279-8740-A4351E58710E</gtr:id><gtr:name>Carl Zeiss AG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1FF61108-E342-4618-805C-FFDCCB826C2F"><gtr:id>1FF61108-E342-4618-805C-FFDCCB826C2F</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Geoffrey</gtr:otherNames><gtr:surname>Spiller</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E34AAE61-B48A-4183-84F9-9AA8802726C3"><gtr:id>E34AAE61-B48A-4183-84F9-9AA8802726C3</gtr:id><gtr:firstName>Violaine</gtr:firstName><gtr:surname>See</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FB39E3B7-C986-4F8C-ADC1-A678A27D2F37"><gtr:id>FB39E3B7-C986-4F8C-ADC1-A678A27D2F37</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Jeffrey</gtr:otherNames><gtr:surname>Beynon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C047998C-37DB-4DCE-98E1-A4BA02F0D930"><gtr:id>C047998C-37DB-4DCE-98E1-A4BA02F0D930</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>White</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FH013725%2F2"><gtr:id>E4DF18AC-27EC-471E-98A9-80D3E65ACF9C</gtr:id><gtr:title>A systems biology study of E2F and NF-kappaB cross-talk</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/H013725/2</gtr:grantReference><gtr:abstractText>We have previously used microscopy to study the important stress signalling system called NF-kappaB, which is present in virtually all mammalian cell types. This system has been shown to be important in inflammatory diseases such as arthritis and asthma, as well as cancer. We showed that NF-kappaB, uses the frequency of movements into and out of the nucleus to determine which genes are switched on. We have found that a transcription factor (a protein which binds to and controls the switching on of other genes) called E2F interacts with the NF-kappaB signalling system. E2F is well known as the principal switch that allows cells to begin to make another copy of their DNA prior to cell division (in a repeating process called the cell cycle). It seems that E2F stops an NF-kappaB signal when there is a high level of this protein inside cells. We found that E2F holds a key NF-kappaB protein called p65 in the nucleus, when it would normally be in the cytoplasm. When NF-kappaB is stimulated, the presence of a high level of E2F causes a delay before oscillations in NF-kappaB movement begin. We wish to investigate 1) the levels of E2F and NF-kappaB proteins at different stages of cell division and which of these proteins bind to each other in the cell. For this we will use mass spectrometry-based measurement of exact protein concentrations and will measure protein interactions using either microscopy or antibodies that allow the precipitation of proteins that bind to each other. Throughout this process we will use and develop a mathematical model of this complicated system. We have already built mathematical models of the NF-kappaB system and we will link these with existing mathematical models of the cell cycle. The mathematical models will be used to predict and interpret the experimental results. The work will therefore allow a new understanding of the relationship between the basic processes of inflammatory signalling (NF-kappaB) and cell division (E2F) which will be important for understanding normal and disease-related inflammation and cell division.</gtr:abstractText><gtr:technicalSummary>We will develop a systems biology programme to study the dynamics of the interactions between the cell cycle/E2F and NF-kappaB systems. We have used cell imaging to characterise a novel physical and functional interaction between the the cell cycle G1/S regulatory transcription factor E2F-1 and the NF-kappaB p65-p50 complex. This interaction mediates differential transcriptional control regulating cellular inflammatory signalling, cell cycle and apoptosis. Increased levels of E2F-1 sequester p65 in the nucleus, reducing NF- kappaB responses to TNFalpha. We will couple our existing deterministic mathematical model for the NF-kappaB system with the most appropriate elements from previously published models of the G1-S transition to develop a predictive mathematical model of the dynamic links between the E2F and NF-kappaB systems. We will use centrifugal elutriation for larger scale cell cycle synchronisation to enable quantitative proteomic and ChIP analyses. We will study the interactions of E2Fs 1,2 and 3 with different NF-kappaB family members to establish whether the different G1-S E2Fs have different interactions with the NF-kappaB system. A preliminary mathematical model has predicted that higher E2F- 1 levels modulate IKK activation following NF-kappaB signalling. We will test the hypothesis that this occurs through the DNA damage-regulated Chk1 and Chk2 kinases. We will make BAC constructs to study the expression and protein localisation of fluorescent reporter-tagged E2F and E2F target genes. We will focus on the regulation of the G1/S cell cycle control genes, Cyclin D1, and Skp2. This will investigate the hypothesis that the E2F and NF-kappaB transcription factors piggy-back onto each others DNA binding sites acting as hybrid transcription factors. We will use transcription analysis from the BAC constructs in single cells to quantify transcriptional noise and variation to investigate the role that this may play in variability of cell cycle timing.</gtr:technicalSummary><gtr:fund><gtr:end>2013-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>467498</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Carl Zeiss AG</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Carl Zeiss</gtr:description><gtr:id>067CFB82-AB68-4576-8875-10784415B39F</gtr:id><gtr:impact>Annual training courses
MICA collaborative MRC grant
MICA collaboration on new single cell centre

The relationship with Zeiss has been two way. We have been given the opportunity to be early adopters f new technology and to feedback idease for improvement. We receive very favourable deals on microscope purchases and maintenance contracts. Specific areas of successful collaboration lie in improvements to higher throughput live cell imaging using the confocal microscopes; optimisation of truly dark microscopes for quantitative luminescence imaging and the development of FCS.

Multiple workshops organised (2-3 per yeat)</gtr:impact><gtr:outcomeId>i8rjFqtYhvF-1</gtr:outcomeId><gtr:partnerContribution>Zeiss have made a cash contribution to training courses (received) of &amp;pound;16,250. Zeiss estimate of total value of in-kind staff time for collaboration, training courses and other meetings (including visits of teams from Germany) ?25,000. In addition, Zeiss have also committed over &amp;pound;30,000 in cash and ~&amp;pound;80000 in in kind staff for future training meetings and collaborative visits. 
Zeiss helped to design the new Systems Microscopy Centre in Manchester and made a 45% discount (value ?350k) for the purchase of equipment in 2011. Zeiss are a formal MICA partner on both Liverpool and Manchester awards from the MRC/BBSRC New Microscopy Initiative. In the award to Manchester they have made a contribution of &amp;pound;614,314 in staff time, development costs and equipment contribution. This involves FCS (developed during this project), luminescence fluorescence imaging, light sheet microscopy and SOFI super-resolution imaging. More recently Zeiss have made a further contribution to our new clinical single cell centre. This includes over &amp;pound;400k in equipment discounts and &amp;pound;25k in cash contribution to training and symposia.
Over the years the Zeiss contributions have included them helping us with public understanding of science exhibitions where they loaned equipment, provided support for professional poster preparation and used their delivery services to transport our exhibit materials and equipment to the exhibition venues. This included an exhibition in Buckingham Palace in 2006.
Zeiss have sponsored 2-3 meetings per year in Manchester. In 2016 this included a session on light sheet imaging and a session on new confocal imaging technologies. In 2017 they have sponsored an image analysis daya and will sponsor a single cell biology workshop.</gtr:partnerContribution><gtr:piContribution>We have advised Zeiss on trends in bioimaging since 1996. We have provided new data and tested prototype equipment. We have spoken at Zeiss organised meetings. We have given them an opportunity to display Zeiss equipment at our training courses. We have organised symposia that have been supported by Zeiss. We have held expert discussion meetings to review microscopy trends that have involved senior Zeiss staff</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4160524</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Strategic Lola</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef> BB/K003097/1</gtr:fundingRef><gtr:id>1D8958BE-586E-4D17-B9CA-CB7B6CD79591</gtr:id><gtr:outcomeId>Xdp7TFUFPEq</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Useful public understanding of science resources that have been used in museums and schools

Mathematical models of cell cycle and NF-kB</gtr:description><gtr:firstYearOfImpact>2010</gtr:firstYearOfImpact><gtr:id>C790C50F-CF75-4191-AF68-B4B53E882EFE</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56ddef61725357.43212373</gtr:outcomeId><gtr:sector>Education,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>identification of key roles for the cell cycle regulating transcription factors E2F1 and E2F4 in interacting with the NF-kB signalling system. These interactions result in a repression of NF-kB responses in S-phase (when DNA replication occurs) and an enhanced response at the checkpoint just before cells enter S-phase. The data suggest an important functional interaction and predictive mathematical models of the cell cycle and NF-kB have been coupled together to predict the behaviour of these systems</gtr:description><gtr:exploitationPathways>The mathematical models will be further developed and part of this has already been done through a PhD studentship

There is great potential to use the coupling between the cell cycle as a paradigm for other coupled systems.

The results are relevant to cancer and chemotherapy responses</gtr:exploitationPathways><gtr:id>27FC0E6A-ADCB-483A-97DC-75AE041DA48B</gtr:id><gtr:outcomeId>5463049e3e10d4.70027352</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Systems Immunology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>48920B83-1AE0-417F-BC7F-BB04C6782ADC</gtr:id><gtr:outcomeId>ikEgUKbYUuJ</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Bioscience for Industry Committee (single meeting for presentation)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>426A453C-4D18-4665-8FCA-6F73CBC2FF1D</gtr:id><gtr:outcomeId>H3Sci3mDtx1</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Invited to attend Research Sponsors' Consultation Meeting (BBSRC &amp;amp;MRC) on Imaging for the biological and biomedical sciences, 14 May 2012.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9BC0B6E7-FEC4-4326-AB7D-E2BB41720A7C</gtr:id><gtr:outcomeId>Vi7N2FEHYfR</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC/EPSRC TDRI Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>433FE4C1-ACB1-4870-93D2-91F6F1E7DABF</gtr:id><gtr:outcomeId>Xms5gDPEt91</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Site visit to Oxford Centre for Systems Biology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>40BAA8E5-E9DF-47CE-A243-87BF2C05084E</gtr:id><gtr:outcomeId>dLQuSozmxAs</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Strategic Tools and Resources Development Fund (sTRDF) Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>41D18AAF-9F3C-468D-B2BC-7DB9A2E64D7F</gtr:id><gtr:outcomeId>Qzw98FM5zsM</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Tools and Resources Development Fund Panel, Feb 2012.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>541BBF0B-5540-452C-99B8-172CC13FF2DD</gtr:id><gtr:outcomeId>tLZAjo7VmqU</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>BBSRC Panel: Enabling Theme 2, the Exploiting New Ways of Working Strategy Panel (ENWW)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4A29E43C-0D08-4040-BB3F-1F06B611BE9C</gtr:id><gtr:outcomeId>riBfcac3je2</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of MRC Population and System Medicine Board, 1 April 2012 - 1 April 2016</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B358B05F-0A83-4D84-8D10-71B6472B2FB5</gtr:id><gtr:outcomeId>GPvJF3EsqEr</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Wellcome Trust/Wolfson Capital Awards in Biomedical Sciences Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BD5F9FFF-3DCE-4C9D-9D5A-AC8AD449EBAC</gtr:id><gtr:outcomeId>RPPFikr7KT7</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of MRC Doctoral Training Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A9C02538-762C-4513-AEC9-DB5AE530EFF0</gtr:id><gtr:outcomeId>E5DDLDFEd7s</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Site visit to Imperial Centre for Systems Biology</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>08F1B8E4-F286-46D2-ACEA-15CD5E6A1C68</gtr:id><gtr:outcomeId>JbZCKGpR49Z</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC/BBSRC New Microscopy Initiative</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6BAD0CEE-2358-456D-B321-D7790DE9F7ED</gtr:id><gtr:outcomeId>E7iSQ5JAkkZ</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Appointed to Pool of Experts for BBSRC Panels, 2012-2013.</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC808638-97A0-4C77-BA98-0E4C31F1FB37</gtr:id><gtr:outcomeId>rgc51j4k6oZ</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Microbiome</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C8FC968F-745D-42EB-A48C-76233AD3011D</gtr:id><gtr:outcomeId>UHVaTGTTYuh</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of BBSRC Research Equipment Initiative (REI) Review Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5769C9B5-3D2B-4964-A59B-F6FD85CEC474</gtr:id><gtr:outcomeId>LaFbgzKTd7U</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of BBSRC Interdisciplinary Systems Biology Strategy Committee</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>0687CAA9-F7C6-4B22-A1AF-0ACE9E55268B</gtr:id><gtr:outcomeId>76DBBCB53BF</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>German Virtual Liver Scientific Advisory Board (42m euros programme )</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>251B1193-E8DB-44E2-B855-BD0AF2E85FEE</gtr:id><gtr:outcomeId>SQ6EWWziHpg</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>http://www.virtual-liver.de/wordpress/en/media/handling-biological-complexity-using-systems-approaches-4/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>External Reviewer for FRISYS-ZBSA (Zentrum fur biosystemanalyse), Freiberg, Germany, 26th May 2011.</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>B246D003-48AD-4656-B64F-2A274318EAE0</gtr:id><gtr:outcomeId>CMtJqz47g26</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>ODE and stochastic models of the NF-kB system and other modules that couple with it</gtr:description><gtr:id>DE08B3C2-E6E5-4F59-90A7-1BE75F248C5D</gtr:id><gtr:impact>Multiple citations with other papers being based on our models</gtr:impact><gtr:outcomeId>546414c786e496.74406010</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mathematical models of NF-kB and inked systems</gtr:title><gtr:type>Computer model/algorithm</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DE897BDA-CB03-4C0D-9CD4-97F587F57358</gtr:id><gtr:title>Quantitative measurement of single cell dynamics.</gtr:title><gtr:parentPublicationTitle>Current opinion in biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46ae951fd0e594cba8c3885122941d7"><gtr:id>a46ae951fd0e594cba8c3885122941d7</gtr:id><gtr:otherNames>Bakstad D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0958-1669</gtr:issn><gtr:outcomeId>pm_5435ad15ad18e64ad</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FF7D524-2696-4BD4-BA9E-1AB6E6C56705</gtr:id><gtr:title>Measurement of single-cell dynamics.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16dd1bc3a81880422ff91e01ec156a56"><gtr:id>16dd1bc3a81880422ff91e01ec156a56</gtr:id><gtr:otherNames>Spiller DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>BFfHFELQHzo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0FC499E-57E6-4C7F-9C6C-5D05E9C54694</gtr:id><gtr:title>Signal transduction controls heterogeneous NF-?B dynamics and target gene expression through cytokine-specific refractory states.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dba0d2441f6590a38f374dcb1bc49357"><gtr:id>dba0d2441f6590a38f374dcb1bc49357</gtr:id><gtr:otherNames>Adamson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d4095207655.83986261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>984823DD-8C0C-47AE-A952-36860FE61206</gtr:id><gtr:title>Cell cycle phase regulates glucocorticoid receptor function.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430ff574c1983d13c6664f0670907bba"><gtr:id>430ff574c1983d13c6664f0670907bba</gtr:id><gtr:otherNames>Matthews L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56dd4374a12407.77885405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0C97717-FA50-462D-9391-4283A411BAEE</gtr:id><gtr:title>Dynamic NF-?B and E2F interactions control the priority and timing of inflammatory signalling and cell proliferation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e38be90a63e0284f712d735e9d2194"><gtr:id>e0e38be90a63e0284f712d735e9d2194</gtr:id><gtr:otherNames>Ankers JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>585d4083671c36.52082726</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/H013725/2</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>A1E1E858-B27A-4BA0-979B-0D0F6938959B</gtr:id><gtr:grantRef>BB/H013725/1</gtr:grantRef><gtr:amount>630088.81</gtr:amount><gtr:start>2010-02-01</gtr:start><gtr:end>2010-09-30</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>E4DF18AC-27EC-471E-98A9-80D3E65ACF9C</gtr:id><gtr:grantRef>BB/H013725/2</gtr:grantRef><gtr:amount>467498.72</gtr:amount><gtr:start>2010-10-01</gtr:start><gtr:end>2013-07-31</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>